BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34499386)

  • 1. Trifecta versus perimount bioprosthesis for surgical aortic valve replacement; systematic review and meta-analysis.
    Yokoyama Y; Kuno T; Takagi H; Fukuhara S
    J Card Surg; 2021 Nov; 36(11):4335-4342. PubMed ID: 34499386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aortic Regurgitation, Time to Aortic Valve Reintervention, and Mortality in Degenerated Trifecta Versus Non-Trifecta Bioprosthesis.
    Abbas AE; Madanat L; Khalili H; Mando R; Kheyrbek M; Chandra R; Niroula S; Hanson I; Dixon S; Renard B; Bloomingdale R; Cami E; Pridham B; Altshuler J; Kindzelski B; Fazzalari F; Shannon F; Vivacqua A
    Am J Cardiol; 2024 Jun; 220():49-55. PubMed ID: 38580038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trifecta Versus Perimount Magna Ease Aortic Valve Prostheses.
    Biancari F; Valtola A; Juvonen T; Husso A; Dahlbacka S; Laakso T; Jalava MP; Tauriainen T; Ahvenvaara T; Kinnunen EM; Niemelä M; Mäkikallio T; Eskola M; Virtanen MPO; Maaranen P; Rosato S; Anttila V; Vento A; Airaksinen J; Raivio P
    Ann Thorac Surg; 2020 Sep; 110(3):879-888. PubMed ID: 32061588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural valve degeneration of bioprosthetic aortic valves: A network meta-analysis.
    Squiers JJ; Robinson NB; Audisio K; Ryan WH; Mack MJ; Rahouma M; Cancelli G; Kirov H; Doenst T; Gaudino M; DiMaio JM
    J Thorac Cardiovasc Surg; 2023 Jul; 166(1):52-59. PubMed ID: 35216819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-year follow-up of aortic valve reoperation rates: Carpentier-Edwards Perimount versus St. Jude Medical Trifecta.
    Stubeda H; Aliter H; Gainer RA; Theriault C; Doucette S; Hirsch GM
    J Card Surg; 2020 Dec; 35(12):3347-3353. PubMed ID: 32985014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Externally mounted versus internally mounted leaflet aortic bovine pericardial bioprosthesis: meta-analysis.
    Yokoyama Y; Sakurai Y; Kuno T; Takagi H; Fukuhara S
    Gen Thorac Cardiovasc Surg; 2023 Apr; 71(4):207-215. PubMed ID: 36598643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trifecta versus Perimount Magna Ease aortic valves: Failure mechanisms.
    Suzuki R; Ito T; Suzuki M; Ohori S; Takayanagi R; Miura S
    Asian Cardiovasc Thorac Ann; 2022 Sep; 30(7):797-806. PubMed ID: 35603636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature Structural Failure of Trifecta Bioprosthesis in Midterm Follow-up: A Single-Center Study.
    Kattach H; Shah BN; Harden S; Barlow CW; Miskolczi S; Velissaris T; Ohri SK
    Ann Thorac Surg; 2021 Nov; 112(5):1424-1431. PubMed ID: 33338482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term durability after surgical aortic valve replacement with the Trifecta and the Intuity valve-a comparative analysis.
    Werner P; Coti I; Kaider A; Gritsch J; Mach M; Kocher A; Laufer G; Andreas M
    Eur J Cardiothorac Surg; 2022 Jan; 61(2):416-424. PubMed ID: 34738111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic valve biologic protheses: A cohort comparison of premature valve failure.
    Yount KW; Hawkins RB; Mehaffey JH; Teman NR; Yarboro LT; Kern JA; Ailawadi G
    J Card Surg; 2022 May; 37(5):1224-1229. PubMed ID: 35245397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reintervention After Aortic Valve Replacement: Comparison of 3 Aortic Bioprostheses.
    Lam KY; Koene B; Timmermans N; Soliman-Hamad M; van Straten A
    Ann Thorac Surg; 2020 Aug; 110(2):615-621. PubMed ID: 31846642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of early hemodynamic performance of 3 aortic valve bioprostheses.
    Ugur M; Suri RM; Daly RC; Dearani JA; Park SJ; Joyce LD; Burkhart HM; Greason KL; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):1940-6. PubMed ID: 24530199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new St Jude Trifecta versus Carpentier-Edwards Perimount Magna and Magna Ease aortic bioprosthesis: is there a hemodynamic superiority?
    Wendt D; Thielmann M; Plicht B; Aßmann J; Price V; Neuhäuser M; Jakob H
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1553-60. PubMed ID: 23870159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durability and Performance of 2298 Trifecta Aortic Valve Prostheses: A Propensity-Matched Analysis.
    Yongue C; Lopez DC; Soltesz EG; Roselli EE; Bakaeen FG; Gillinov AM; Pettersson GB; Semple ME; Rajeswaran J; Tong MZ; Jaber W; Blackstone EH; Svensson LG; Johnston DR
    Ann Thorac Surg; 2021 Apr; 111(4):1198-1205. PubMed ID: 33011168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival after Carpentier-Edwards Perimount aortic valve replacement in Western Denmark: a multi-centre observational study.
    Krasniqi L; Kronby MP; Riber LPS
    J Cardiothorac Surg; 2021 May; 16(1):130. PubMed ID: 33990211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Matched-Paired Comparative Analysis of the Hemodynamics of the Trifecta and Perimount Aortic Bioprostheses.
    Rubens FD; Rao RV; Chan V; Burwash IG
    J Heart Valve Dis; 2015 Jul; 24(4):487-95. PubMed ID: 26897822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-Term Clinical Outcomes and Hemodynamic Performances of Trifecta and Perimount Bioprostheses following Aortic Valve Replacement.
    Toto F; Leo L; Klersy C; Torre T; Theologou T; Pozzoli A; Caporali E; Demertzis S; Ferrari E
    J Cardiovasc Dev Dis; 2023 Mar; 10(4):. PubMed ID: 37103018
    [No Abstract]   [Full Text] [Related]  

  • 18. Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis.
    Virtanen MPO; Eskola M; Savontaus M; Juvonen T; Niemelä M; Laakso T; Husso A; Jalava MP; Tauriainen T; Ahvenvaara T; Maaranen P; Kinnunen EM; Dahlbacka S; Laine M; Mäkikallio T; Valtola A; Raivio P; Rosato S; D'Errigo P; Vento A; Airaksinen J; Biancari F
    J Cardiothorac Surg; 2020 Jun; 15(1):157. PubMed ID: 32600369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive hemodynamic comparison and frequency of patient-prosthesis mismatch between the St. Jude Medical Trifecta and Epic Bioprosthetic aortic valves.
    Yadlapati A; Diep J; Barnes M; Grogan T; Bethencourt DM; Vorobiof G
    J Am Soc Echocardiogr; 2014 Jun; 27(6):581-9. PubMed ID: 24534651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.